Tuesday, 4 June 2013

Evergreening strategies--where pharmaceutical companies slightly change the formulation of their brand drug into "follow on" drugs by combining formulations or producing slow-release forms, for example, so that they can extend the patent--substantially contributed to an increase in overall healthcare costs in the Swiss canton of Geneva, according to a study by international researchers published in this week's PLOS Medicine...


Post a Comment


Powered by Blogger.

ads 3

Popular Posts

ads 4

ads 5